Trial · NCT04965870
A Study of Trifluridine/ Tipiracil in Chemorefractory mCRC in Greece
NCT04965870, Completed, Hellenic Study Group of Psychoneuroimmunology in Cancer
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. A Study of Trifluridine/ Tipiracil in Chemorefractory mCRC in Greece. Trials, record NCT04965870. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04965870
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study of Trifluridine/ Tipiracil in Chemorefractory mCRC in Greece
- NCT number
- NCT04965870
- Status
- Completed
- Enrollment
- 200 participants, actual
- Lead sponsor
- Hellenic Study Group of Psychoneuroimmunology in Cancer
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- Trifluridine/Tipiracil
- First posted
- 2021-07-16
- Last updated
- 2022-03-07
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Progression Free Survival | Retrospective data analysis from January 2018 to at least 3 months prior to being included in the study. | PFS is defined as the time interval from initiation of treatment to the first date of documented tumor progression or death from any cause, whichever occurs first. |
| Secondary | Overall Survival | Retrospective data analysis from January 2018 to at least 3 months prior to being included in the study. | Overall survival is defined as the time interval from initiation of treatment to the date of death due to any cause. |
| Secondary | Progression Free Survival rate at 6 and 8 months | Retrospective data analysis from January 2018 to at least 3 months prior to being included in the study. | PFS rate at 6 and 8 months corresponding to the percentage of patients surviving without any documented progression of the disease at 6 and 8 months after treatment initiation. |
| Secondary | Disease Control Rate | Retrospective data analysis from January 2018 to at least 3 months prior to being included in the study. | The DCR is defined as the proportion of patients with objective evidence of complete response (CR), the proportion of patients with objective evidence of partial response (PR), and the proportion of patients with objective evidence of stable disease (SD). |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04965870
GET https://conductscience.org/api/trials/v1/NCT04965870/registered